Ventura, Baby Boy R.

HRN: 22-23-65  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2022
AMPICILLIN 250MG (VIAL)
11/21/2022
11/28/2022
IVT
200 Mg
6 Hrs
PCAP D
Waiting Final Action 
11/21/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/21/2022
11/28/2022
IVT
40 Mg
24 Hrs
PCAP D
Waiting Final Action 
11/24/2022
CEFTAZIDIME 1GM (VIAL)
11/24/2022
12/01/2022
IVT
140 Mg
8 Hrs
PCAP D
Waiting Final Action 
11/26/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/26/2022
12/03/2022
IV
200
Q6
Pcap D
Waiting Final Action 
11/26/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/26/2022
12/03/2022
IV
170mg
Q6
Pcap D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: